Org 36286
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Org 36286, covering 2024-08-15 to 2024-08-15. Get the full timeline:
Most recent: Clinical Trial Update: Study to Investigate the Optimal Dose of Org 36286 to Induce Monofollicular Ovulation in Women With WHO Group II Anovulatory Infertility (P07016) [Phase 2]